SCM
Stonepine Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
250,000
+214,852
| +611% | +$1.01M | 1.16% | 23 |
|
|
2025
Q1 | $161K | Buy |
35,148
+10,148
| +41% | +$46.6K | 0.16% | 53 |
|
|
2024
Q4 | $120K | Buy |
+25,000
| New | +$120K | 0.1% | 46 |
|
|
2023
Q4 | – | Sell |
-477,903
| Closed | -$2.06M | – | 21 |
|
|
2023
Q3 | $2.06M | Buy |
+477,903
| New | +$2.06M | 0.69% | 22 |
|
|
2019
Q3 | – | Sell |
-1,341,943
| Closed | -$18.9M | – | 28 |
|
|
2019
Q2 | $18.9M | Buy |
1,341,943
+81,655
| +6% | +$1.15M | 13.02% | 2 |
|
|
2019
Q1 | $23.2M | Buy |
1,260,288
+1,039,440
| +471% | +$19.1M | 13.34% | 1 |
|
|
2018
Q4 | $5.77M | Sell |
220,848
-103,752
| -32% | -$2.71M | 5.07% | 8 |
|
|
2018
Q3 | $7.45M | Sell |
324,600
-275,400
| -46% | -$6.32M | 4.36% | 8 |
|
|
2018
Q2 | $11.4M | Sell |
600,000
-384,584
| -39% | -$7.33M | 6.95% | 5 |
|
|
2018
Q1 | $16.6M | Buy |
984,584
+99,584
| +11% | +$1.68M | 8.89% | 4 |
|
|
2017
Q4 | $13.5M | Buy |
885,000
+585,000
| +195% | +$8.89M | 8.06% | 4 |
|
|
2017
Q3 | $5.37M | Sell |
300,000
-385,086
| -56% | -$6.89M | 3.17% | 14 |
|
|
2017
Q2 | $11.2M | Buy |
685,086
+641,786
| +1,482% | +$10.5M | 6.03% | 5 |
|
|
2017
Q1 | $606K | Buy |
+43,300
| New | +$606K | 0.34% | 20 |
|
|
2016
Q3 | – | Sell |
-811,563
| Closed | -$9.08M | – | 21 |
|
|
2016
Q2 | $9.08M | Sell |
811,563
-1,256,734
| -61% | -$14.1M | 9.31% | 4 |
|
|
2016
Q1 | $17.3M | Buy |
2,068,297
+149,368
| +8% | +$1.25M | 20.39% | 2 |
|
|
2015
Q4 | $17.9M | Buy |
+1,918,929
| New | +$17.9M | 20.93% | 1 |
|